Theracos — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Theracos appears in 21 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials21

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

21 shown

Absolute Bioavailability Study With BexagliflozinNCT03417076 · lead sponsor · 2018-08-01

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic ImpairmentNCT03557658 · lead sponsor · 2018-07-26

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsNCT03259789 · lead sponsor · 2017-11-28

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential HypertensionNCT03514641 · lead sponsor · 2017-10-18

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsNCT03115112 · lead sponsor · 2017-10-12

Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy SubjectsNCT03296800 · lead sponsor · 2017-09-27

Bexagliflozin Drug/Drug Interaction Study With DigoxinNCT03197324 · lead sponsor · 2017-07-24

Bexagliflozin Drug/Drug Interaction Study With Exenatide InjectionNCT03167411 · lead sponsor · 2017-05-24

Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinNCT02956044 · lead sponsor · 2016-11-01

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal ImpairmentNCT02836873 · lead sponsor · 2016-09-23

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsNCT02769481 · lead sponsor · 2016-08-15

Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy SubjectsNCT02820298 · lead sponsor · 2016-06-20

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesNCT02715258 · lead sponsor · 2016-03-01

Bexagliflozin Efficacy and Safety TrialNCT02558296 · lead sponsor · 2015-10-01

A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusNCT02390050 · lead sponsor · 2015-05-12

Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes MellitusNCT01377844 · lead sponsor · 2011-12-01

Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy SubjectsNCT01155531 · lead sponsor · 2010-05-01

Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusNCT01029704 · lead sponsor · 2009-12-01

Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 DiabetesNCT00924053 · lead sponsor · 2009-06-01

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy VolunteersNCT00854113 · lead sponsor · 2009-02-01

Efficacy and Safety of THR-4109 in Obese SubjectsNCT00485017 · lead sponsor · 2007-08-01

Sponsor roles

lead sponsor21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.